Press Releases

Date Title and Summary Additional Formats
Toggle Summary 6 Samples Across 92 Proteins In One Microfluidic Run
Fluidigm and Olink Bioscience Bring a New Level of Protein Biomarker Discovery to the Market
View HTML
Toggle Summary Australia's First Single-Cell genomics Centre of Excellence Opens at Monash HTP
Through an innovative and entrepreneurial approach to genomics medicine, the Centre intends to accelerate scientific discoveries.   MELBOURNE, Australia and SOUTH SAN FRANCISCO, California, Sept. 4, 2015 – A partnership among Monash University, the University of Melbourne, the University of
View HTML
Toggle Summary Brad Kreger Joins Fluidigm as Senior Vice President, Global Operations
SOUTH SAN FRANCISCO, Calif. , April 23, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Brad Kreger as Senior Vice President, Global Operations. In this role, Kreger leads global manufacturing, supply chain, demand planning, and distribution for
View HTML
Toggle Summary C1 Single-Cell Auto Prep System Wins Prestigious Award
Fluidigm C1 Single-Cell Auto Prep System Wins Prestigious IBO Design Award Recognized for Excellence in Analytical Instrument Industrial Design
View HTML
Toggle Summary Custom High-Throughput Prep System For Hla Typing
Fluidigm to Develop and Supply a Custom High-throughput Prep System for HLA Typing Custom system will ultimately enable DKMS Life Science Lab to type several thousand samples per week
View HTML
Toggle Summary Dvs Sciences Introduces The Cytof® 2
DVS Sciences introduces the CyTOF® 2 mass cytometer and new MaxPar® Panel Kits for transformational high‐parameter single cell analysis
View HTML
Toggle Summary Early Access Program For New Imaging Mass Cytometry Platform
SOUTH SAN FRANCISCO, Calif., July 31, 2014 - Fluidigm Corporation (NASDAQ:FLDM) has begun accepting applications to an early access program for its upcoming imaging mass cytometry platform. Prototypes of the product are expected to begin shipping to early access partners by the end of this year.
View HTML
Toggle Summary European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research
SOUTH SAN FRANCISCO, Calif. , May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that leading research institutions in the UK have partnered to acquire and implement seven Helios™ mass cytometry systems to empower life-changing discoveries in human health.
View HTML
Toggle Summary Financial Results For Third Quarter 2013
Strong Q3 2013 revenue growth of 43%
View HTML
Toggle Summary Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China
SOUTH SAN FRANCISCO, Calif. and ZHONGSHAN , China , July 27, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Ascendas Genomics today announced a strategic partnership to develop molecular diagnostics in China . Under the terms of the partnership, Ascendas Genomics will develop and
View HTML